Differences in the phenotype, cytokine gene expression profiles and in vivo alloreactivity of T cells mobilized with plerixafor compared to G-CSF

Plerixafor (Mozobil(®)) is a CXCR4 antagonist that rapidly mobilizes CD34+ cells into circulation. Recently, plerixafor has been used as a single agent to mobilize peripheral blood stem cells (PBSC) for allogeneic hematopoietic cell transplantation. Although G-CSF mobilization is known to alter the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lundqvist, Andreas, Smith, Aleah L., Takahashi, Yoshiyuki, Wong, Susan, Bahceci, Erkut, Cook, Lisa, Ramos, Catalina, Tawab, Abdul, McCoy, J. Philip, Read, Elizabeth J., Khuu, Hanh M., Bolan, Charles D., Jungnam, Joo, Geller, Nancy, Leitman, Susan F., Calandra, Gary, Dunbar, Cynthia, Kurlander, Roger, Childs, Richard W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3892143/
https://ncbi.nlm.nih.gov/pubmed/24244025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1301148
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados